Skip to content

Photobiomodulation Laser Therapy Following Arthroscopic Rotator Cuff Repair

Evaluation of the Efficacy of B-Cure Laser Treatment on Pain and Functionality Following Arthroscopic Rotator Cuff Repair: A Prospective Double Blind, Randomized, Sham-Controlled Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04593342
Acronym
LLL&RotC01
Enrollment
53
Registered
2020-10-20
Start date
2020-11-26
Completion date
2022-04-11
Last updated
2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Tears

Keywords

Photobiomodulation, Low-Level Laser Therapy

Brief summary

Rehabilitation following rotator cuff surgery is characterized with high levels of pain, limited range of motion, and decreased quality of life. The purpose of this study is to evaluate the B-Cure laser photobiomodulation home-use device in addition to standard care, for the reduction of pain, increase in functionality, and improvement of life quality during rehabilitation following rotator cuff arthroscopic surgery.

Detailed description

Patients planned to undergo rotator cuff arthroscopy will be randomized to receive active or sham devices for self-application at home in addition to standard care. Patients will be invited to up to 5 visits at the clinic: baseline (before surgery), post-operative day 1, and 1, 3, and optionally 6 months after surgery. Evaluations will include physical examination, physical activity tests, range of motion measurements, Constant score, thermal imaging, and patient reported outcomes including subjective pain level by visual analogue scale, functional and quality of life questionnaires. The study hypothesis is that B-Cure laser treatments, applied, at home, by the patient, can reduce pain and accelerate healing over standard care thereby improving the rehabilitation process following rotator cuff arthroscopic surgery.

Interventions

The B-Cure laser Pro is a portal, non-invasive, low level laser therapy device, that emits light in the near infrared (808nm) over an area of 1X4.5 cm2 with power output of 250mW, and energy dose of 5J/min.

DEVICESham

The sham device is externally identical to the B-Cure Pro and emit the same guiding light, but does not emit the therapeutic near infrared rays.

Sponsors

Holy Family Hospital, Methuen, MA
CollaboratorOTHER
Erika Carmel ltd
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Sham control

Intervention model description

Single center, Prospective, Double Blind, Randomized, Sham-Controlled, Parallel Group, Superiority comparison

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 40-65 * Men or women * Full or partial rotator cuff tear * Scheduled to undergo RCAS because of failure of conservative therapy (injections, medication, physiotherapy) * Is willing to perform the full protocol * Voluntarily sign and date an informed consent form * Be able to understand and complete the various questionnaires

Exclusion criteria

* Is unwilling or unable to cooperate with the requirements of the study including completion of all scheduled study visits * Participation in another clinical study within 30 days before screening * Scheduled to undergo an elective medical procedure during the study timeframe that will interfere with the study as deemed by the PI * Pregnant * Has any photobiomodulation (low level laser) device at home or has previously used photobiomodulation for shoulder pain * Use of medications, herbal supplements, perfumes or cosmetics that may affect sensitivity to light * Has osteoarthritis * Other chronic pain conditions: fibromyalgia, failed back surgery, back pain * Avascular necrosis * Rheumatoid arthritis * Psychiatric disorders including major depression, schizophrenia, bipolar disease

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in level of pain by VAS1 month post-surgerySubject assessment of pain will be evaluated using a Visual Analogue Scale (VAS), were 0 is no pain and 100 is intolerable pain.

Secondary

MeasureTime frameDescription
Change from baseline in functionality (CONSTANT score)1 month post-surgeryThe CONSTANT score used to assess the functionality of the shoulder by clinicians. The range of the score is 0-100. The higher the score, the higher the quality of the function.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026